Alzamend Neuro (ALZN) Earnings Yield: History & Chart

Alzamend Neuro Inc(ALZN)

Biotechnology · Atlanta, GA

$1.41-0.00 (-0.11%)

Delayed quote: Oct 6, 2026, 10:46 AM EDT

About Alzamend Neuro Inc

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Atlanta, GA

6 employees

www.alzamend.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Stephan Jackman

View full financials

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Alzamend Neuro Inc (ALZN)	$5.36M	N/A	N/A	N/A	N/A
Intelligent Bio Solutions Inc. (INBS)vs ›	$5.27M	N/A	N/A	N/A	N/A
Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs ›	$5.21M	N/A	N/A	N/A	N/A
Lunai Bioworks Inc. (LNAI)vs ›	$5.19M	N/A	N/A	N/A	N/A
Acurx Pharmaceuticals, Inc. (ACXP)vs ›	$5.54M	N/A	N/A	N/A	N/A
Gelteq Limited Ordinary Shares (GELS)vs ›	$5.17M	N/A	N/A	N/A	N/A
Imunon, Inc. (IMNN)vs ›	$5.04M	N/A	63.50%	63.50%	63.50%
enVVeno Medical Corporation (NVNO)vs ›	$5.70M	N/A	N/A	N/A	N/A
Basel Medical Group Ltd Ordinary Shares (BMGL)vs ›	$5.01M	N/A	N/A	N/A	N/A
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs ›	$5.85M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EARNINGS YIELD

TTM

Alzamend Neuro Inc (ALZN)

$5.36M

N/A

Intelligent Bio Solutions Inc. (INBS)vs ›

$5.27M

N/A

Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs ›

$5.21M